Personal information

No personal information available

Activities

Collapse all

Employment (1)

Proton Therapy Centre: Prague, CZ

Employment
Source: Self-asserted source
Michal Andrlík

Works (10)

5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis

Cancers
2023-09 | Journal article | Author
DOI: 10.3390/cancers15184571
Contributors: Jiri Kubeš; Silvia Sláviková; Pavel Vítek; Alexandra Haas; Barbora Ondrová; Kateřina Dedečková; Michal Andrlík; Martin Domanský; Kateřina Jiránková; Veronika Schlencová et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Pencil‐beam scanning proton therapy for the treatment of glomus jugulare tumours

Journal of Medical Radiation Sciences
2022-08-16 | Journal article
DOI: 10.1002/jmrs.612
Part of ISSN: 2051-3895
Part of ISSN: 2051-3909
Contributors: Michal Andrlík
Source: Self-asserted source
Michal Andrlík

Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection

International Journal of Radiation Oncology*Biology*Physics
2022-03 | Journal article
DOI: 10.1016/j.ijrobp.2021.10.151
Part of ISSN: 0360-3016
Contributors: Michal Andrlík
Source: Self-asserted source
Michal Andrlík

Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer—Single Institution Experience

Cancers
2021-12 | Journal article | Author
DOI: 10.3390/cancers14010185
Contributors: Pavel Vítek; Jiří Kubeš; Vladimir Vondracek; Michal Andrlík; Matěj Navrátíl; Radek Zapletal; Alexandra Haas; Kateřina Dědečková; Barbora Ondrová; Alexander Grebenyuk et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes

International Journal of Radiation Oncology*Biology*Physics
2021-07 | Journal article
DOI: 10.1016/j.ijrobp.2021.02.014
Part of ISSN: 0360-3016
Contributors: Michal Andrlík
Source: Self-asserted source
Michal Andrlík

Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results

European Archives of Oto-Rhino-Laryngology
2021-03 | Journal article
DOI: 10.1007/s00405-020-06175-5
Part of ISSN: 0937-4477
Part of ISSN: 1434-4726
Contributors: Michal Andrlík
Source: Self-asserted source
Michal Andrlík

Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results

Journal of Medical Imaging and Radiation Oncology
2019-12 | Journal article
DOI: 10.1111/1754-9485.12947
Part of ISSN: 1754-9477
Part of ISSN: 1754-9485
Contributors: Michal Andrlík
Source: Self-asserted source
Michal Andrlík

LOW DOSE BATH FROM IMPT VS. IMXT FOR THE PELVIC AREA WHEN TREATING ADVANCED PROSTATE CANCER

Radiation Protection Dosimetry
2019-12-31 | Journal article
DOI: 10.1093/rpd/ncz235
Part of ISSN: 0144-8420
Part of ISSN: 1742-3406
Contributors: Michal Andrlík
Source: Self-asserted source
Michal Andrlík

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

Practical Radiation Oncology
2019-05 | Journal article
DOI: 10.1016/j.prro.2019.01.006
Part of ISSN: 1879-8500
Contributors: Michal Andrlík
Source: Self-asserted source
Michal Andrlík

MEASUREMENT OF SECONDARY NEUTRONS GENERATED DURING PROTON THERAPY

Radiation Protection Dosimetry
2016-12 | Journal article
DOI: 10.1093/rpd/ncv504
Part of ISSN: 0144-8420
Part of ISSN: 1742-3406
Contributors: Michal Andrlík
Source: Self-asserted source
Michal Andrlík

Peer review (1 review for 1 publication/grant)

Review activity for International journal of radiation oncology, biology, physics. (1)
How many people are using ORCID?